U.S. Microrna Market Size & Outlook, 2023-2030
U.S. microrna market, 2018-2030 (US$M)
Related Markets
U.S. microrna market highlights
- The U.S. microrna market generated a revenue of USD 609.0 million in 2023 and is expected to reach USD 1,327.9 million by 2030.
- The U.S. market is expected to grow at a CAGR of 11.8% from 2024 to 2030.
- In terms of segment, services was the largest revenue generating services scope in 2023.
- Services is the most lucrative services scope segment registering the fastest growth during the forecast period.
Microrna market data book summary
| Market revenue in 2023 | USD 609.0 million |
| Market revenue in 2030 | USD 1,327.9 million |
| Growth rate | 11.8% (CAGR from 2023 to 2030) |
| Largest segment | Services |
| Fastest growing segment | Services |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Services, Products Type |
| Key market players worldwide | Thermo Fisher Scientific Inc, Qiagen NV, Horizon Discovery, NanoString Technologies, Merck KGaA, Takara Bio Inc, LGC Group, Biogenex, New England Biolabs, GeneCopoeia |
Other key industry trends
- In terms of revenue, U.S. accounted for 38.5% of the global microrna market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In North America, U.S. microrna market is projected to lead the regional market in terms of revenue in 2030.
- Canada is the fastest growing regional market in North America and is projected to reach USD 158.5 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
MicroRNA Market Scope
MicroRNA Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
U.S. microrna market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to microrna market will help companies and investors design strategic landscapes.
Services was the largest segment with a revenue share of 58.39% in 2023. Horizon Databook has segmented the U.S. microrna market based on services, products type covering the revenue growth of each sub-segment from 2018 to 2030.
Major market players, such as Thermo Fisher Scientific, Agilent Technologies, Inc., and Illumina, Inc., are headquartered in the U.S. These players operate through a well-established distribution network. The miRNA products and services are easily available in the country.
Furthermore, these players have a strong focus on R&D that makes robust technology support to customers in the country. For instance, in August 2021, researchers at the Texas Heart Institute unveiled novel insights into disease through miRNA profiling.
This underscores the significant role of miRNAs in regulating gene expression and their implications in various biological processes & disease pathogenesis. Furthermore, companies such as Regulus Therapeutics Inc., miRagen Therapeutics, Inc., Santaris Pharma (now merged with Roche), and Mirna Therapeutics, Inc. (now Synlogic, Inc.) have entered the U.S. market.
Reasons to subscribe to U.S. microrna market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of U.S. microrna market databook
-
Our clientele includes a mix of microrna market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the U.S. microrna market , including forecasts for subscribers. This country databook contains high-level insights into U.S. microrna market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
U.S. microrna market size, by services scope, 2018-2030 (US$M)
U.S. MicroRNA Market Outlook Share, 2023 & 2030 (US$M)
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
